Literature DB >> 9170024

Acute myopathy induced by colchicine in a cyclosporine-treated renal transplant recipient--a case report and review of the literature.

B I Lee1, S J Shin, S N Yoon, Y J Choi, C W Yang, B K Bang.   

Abstract

We report a case of colchicine-induced myopathy related to short-term, customary administration of colchicine. A 49-year-old male was admitted because of muscle weakness and myalgia that had developed 10 days previously. He had received renal transplantation 5 years previously and took cyclosporine as an immunosuppressant. Two weeks before admission, gout was developed and he took colchicine (1.2 mg b.i.d) by himself for three days. Colchicine-induced myopathy was clinically suspected, and colchicine intake was stopped immediately. After that, clinical symptoms gradually improved and serum muscle enzyme returned to normal. In this case, mild renal dysfunction and drug interaction between cyclosporine and colchicine wee suggested to be the precipitating factors of colchicine-induced myopathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9170024      PMCID: PMC3054234          DOI: 10.3346/jkms.1997.12.2.160

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  4 in total

1.  Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient.

Authors:  Kyungmin Huh; Ji Young Joung; Hyemin Jeong; Dongmo Je; Yoon Young Cho; Hye Ryoun Jang; Wooseong Huh
Journal:  Kidney Res Clin Pract       Date:  2013-05-23

2.  Colchicine-Induced Acute Neuromyopathy in a Patient Using Concomitant Fluconazole: Case Report and Literature Review.

Authors:  Yi-Chia Su; Chih-Chien Wu
Journal:  Drug Saf Case Rep       Date:  2015-12

3.  Clinical outcomes after colchicine overdose: A case report.

Authors:  Mingjie Fu; Jie Zhao; Zhitao Li; He Zhao; Anwei Lu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 4.  Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review.

Authors:  Huai Leng Pisaniello; Mark C Fisher; Hamish Farquhar; Ana Beatriz Vargas-Santos; Catherine L Hill; Lisa K Stamp; Angelo L Gaffo
Journal:  Arthritis Res Ther       Date:  2021-04-28       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.